Abstract: A cranberry based dietary supplement or dental hygiene product is revealed with enhanced flavor characteristics. Cranberry sources are combined with extracts of the fruit of Lou Han Kuo and/or extracts from the leaves of Stevia rebaudiana and/or extracts from the leaves of Chinese Blackberry. Extract from the root of Chinese licorice is used as a stabilizer in the composition. The resulting product is a pleasant tasting dietary supplement, which is easily absorbed by the body in liquid form, and provides substantially therapeutic effects.

Abstract: Methods of using pomegranate extracts of the present invention for treating patients with atherosclerosis, or increased intima-media thickness of an artery, are provided. The methods comprise the step of administering to the patient a composition comprising a therapeutically effective amount of an extract from pomegranate. The methods of the present invention may also be used to decrease the incidence of stroke or heart attack in a patient.

Abstract: A light colored standardized extract of Emblica officinalis consisting essentially of over 40% by weight of Emblicanin A. Emblicanin B, Pedunculagin and Punigluconin, and not more than about 1% by weight of flavonoids, and methods of producing same. Also disclosed are cosmetic or pharmaceutical compositions comprising the standardized extract and methods of using same to lighten or whiten skin.

Abstract: Disclosed are several preferred embodiments of hydrogen peroxide which are packaged with ease of use and extended shelf-life in mind. The embodiments include foam, mist, gel, and disposable towelette forms of H2O2. Optional ingredients of topical pain relievers and skin protectants are also disclosed, as are their methods of use.

Abstract: Methods of prophylaxis or treatment of a disease state initiated by or characterized by platelet aggregation, that employ a fruit extract or active fraction thereof, are disclosed. In one embodiment, the fruit extract or active fraction thereof, is obtained from the fruit of plants of the families Solanaceae, Rutaceae, Cucurbitaceae, Rosaceae, Musaceae, Anacardiaceae, Bromeliaceae, Vitaceae, Arecaceae, Ericaceae and Lauraceae. Pharmaceutical compositions comprising a fruit extract or active fraction thereof having platelet aggregation inhibitory activity are also disclosed.

Abstract: A hepatic disorder suppressant comprising extracts having hepatic disorder suppressing effect as effective ingredients, wherein the extracts is obtained by extracting an avocado plant and/or a processed product thereof with an organic solvent is disclosed.

Abstract: A method and composition for treating herpes zoster varicella and related afflictions is provided. The method is achieved by diagnosing an individual affected with the herpes varicella zoster virus or related afflictions and applying a medicine to the affected area. The medicine comprises anti-viral proteins of a pokeweed plant.

Abstract: The present invention provides a composition including at least six of the following traditional Chinese medicines: Ren Shen, Dang Gui, Huang Qi, Gan Cao, Chai Hu, Huang Lian, Tian Zhu Huang, Huang Qin. The composition possesses pharmaceutical activities of inhibiting platelet aggregation and prolonging bleeding time, and can be used in preventing and treating a cerebrovascular disease.

Abstract: A herbal therapeutic composition is provided which enhances cardiac function comprising hawthorn berry, turmeric root and cayenne pepper. Other herbal substituents which further enhance this novel composition are disclosed including motherwort, bilberry, fresh dandelion root, and ginger root.

Abstract: The invention is directed to a dietary supplement which contains mannoheptulose. Mannoheptulose occurs naturally in avocado fruit. The dietary supplement and its method of use can lower serum insulin levels and lower a subject's weight. The dietary supplement in its disclosed form includes a controlled release system for mannoheptulose. The dietary supplement may also include one or more amino acids.

Abstract: The present invention is concerned with nutritional or pharmaceutical compositions containing an extract or concentrate of a plant from the genus Lycopersicon. The compositions of the invention are useful for the treatment or prophylaxis of diseases or conditions which are characterized by increased bone resorption, such as Paget's disease, tumor-induced bone disease or particularly osteoporosis.

Abstract: A fruit polyphenol obtained by subjecting a crab apple fruit to pressing and/or extraction. The fruit polyphenol is rich in such components as condensed tannins (procyanidins), chlorogenic acid, and epicatechin. The fruit polyphenol can be produced economically and efficiently.

Abstract: The present invention features a unique, natural formulation and method of administering the same to treat and prevent diabetes, or rather advances treatment of diabetes, by providing a naturaceutical composition or treatment formulated with one or more processed Morinda citrifolia products as derived from the Indian Mulberry plant. The Morinda citrifolia is particularly adapted to treat Type II diabetes. The Morinda citrifolia product is preferably a leaf extract, but may also be in the form of a juice, a puree juice, a dietary fiber, or other similar forms and is incorporated into various carriers or naturaceutical compositions suitable for in vivo treatment of a patient. The naturaceutical may also combine other food products into the naturaceutical, such as fruit juices, dietary supplements, vitamins and minerals, and others.

Abstract: The present invention relates to a novel synergistic herbal composition for the treatment of gastric ulcer, a method for preparing said synergistic herbal composition and a process for the treatment of gastric ulcer using said composition and more particularly, the present invention relates to a novel synergistic herbal composition which is effective against pyloric ligation induced ulcer model and histamine induced ulcer model.

Abstract: The present invention provides a method for treating patients with liver diseases by co-administrating a pharmaceutical composition and lamivudine to the patients. The pharmaceutical composition is a herbal mixture which contains, as the core ingredients, the aqueous extracts of the entire plant of Herba Hedyotidis diffusae, the rhizome of Rhizoma Bistortae, the rhizome of Rhizoma Polygoni Cuspidati, and the ripe fruit of Fructus Schisandrae. The present invention also provides methods for preventing a relapse of hepatitis in patients after the lamivudine treatment has been discontinued and for suppressing the development of lamivudine drug resistance in patients by providing the lamivudine-treated patients with the pharmaceutical composition of the present invention.

Abstract: The use of an improved method for freeze concentration is disclosed. The method provides for first freezing components of a pulpy slurry of Morinda citrifolia. More dilute components are extracted after the initial freezing. A secondary freezing process at a lower temperature allows more concentrated portions of a Morinda citrifolia slurry to be removed. Flavor and therapeutic oils remain in the resulting concentrate for improved flavor and health benefits.

Abstract: The invention provides herbal compositions with antiviral properties comprising extracts of Foeniculum vulgare, Nigella sativa, Centaurium erythrae (spicatum or pulchellum), Cynara cardunculus var scolymus, Inula helenium (viscosa), Solenostema argel, Sesbania aegyptiaca (sesban), Cichorium intybus (pumilum), Cymbopogon proximus, Hemidesmus indicus, Rheum officinale, Cuminum cyminum, and combinations thereof. The invention further provides herbal compositions with antiviral properties comprising an extract from the leaves or seed of Sesbania aegyptiaca (sesban) and at least one additional herbal extract selected from the group consisting of seed of Nigella sativa, shoot of Cichorium intybus (pumilum), whole plant of Cymbopogon proximus, rhizome of Hemidesmus indicus, leaves of Solenostema argel, rhizome of Rheum officinale, and fruit of Ecballium elaterium.

Abstract: The invention discloses a medicine that can treat CRF and the preparation method of it, which mainly make up of fleece-flower root, dodder, pseudostellaria root, atractylodes rhizome, wolfberry fruit, Achyranthes root the invented medicine absorb quickly, have good curative effect, with high content of effective component and admit is convenience.

Abstract: A therapeutic herbal composition is beneficial for enhancing the immune system and treating such a diverse range of diseases as cancer, AIDS, Epstein Barr syndrome and depression. It is also useful as a general blood tonic. This composition includes the synergistic combination of Boswelia carterii stem resin, Styrax benzoin stem resin, Cinnamomum zeylanicum bark, Curcuma zedoaria root, Syzygium aromaticum fruit, Nardostachys chinensis root, Betula alba bark, Impatiens balsamina bark, Costus spicatus root, Allilum sativum bulb and Cyperus rotundus root.

Abstract: Noni juice and a protein-free, alcohol precipitate of Noni juice inhibited angiogenesis in in vitro human angiogenesis models. When growth medium contained Noni juice at least over the range from about 2.5% to about 33% (by volume), angiogenesis was blocked. Moreover, Noni juice and an ethanol precipitate were able to destroy a pre-existing angiogenic response as well as prevent the development of new vessels. Noni juice was effective in inhibiting the growth of angiogenic vessels from breast cancer explants. It will also be effective in treating cancers and non-cancerous diseases whose response includes an increase in angiogenesis, e.g., retinopathy of prematurity, neovascular glaucoma, diabetic retinopathy, and psoriasis. The primary antiangiogenic component is believed to be a carbohydrate with a molecular weight less than about 6000 Daltons. In an initial experiment, oral administration of Noni juice appeared to adversely affect the antioangiogenic component(s) in the juice.

Abstract: A method and composition for treating herpes zoster varicella and related afflictions is provided. The method is achieved by diagnosing an individual affected with the herpes varicella zoster virus or related afflictions and applying a medicine to the affected area. The medicine comprises anti-viral proteins of a pokeweed plant.

Abstract: A water soluble extract from a plant of Solanum genus consists essentially of at least 60%-90% of solamargine and solasonine. A process for preparing the water soluble extract from the plant of Solanum genus involves the steps of hydrolysis with an acid, precipitation with a base, and separation treatments using chloroform, alcohol and water as extraction solvents. The water soluble extract prepared from the process can be directly dissolved in pure or neutral pH water to form a yellowish clear and transparent aqueous solution having a water solubility ranging from 2˜20 mg/ml or higher.

Abstract: A sport fishing system having: a rod and reel, including fishing line; at least one fishing lure or natural bait; and a controlled released fish attractant for applying to the fishing lure or natural bait. The system may further include an applicator for applying the controlled released fish attractant to the fishing lure or natural bait. In the preferred embodiment, the controlled release fish attractant includes: an attractant and a substantially hydrophobic, film forming release agent.

Abstract: The present invention relates to a process of extracting haw pits by dry distillation and the device used therein. The process includes the following steps: removing the impurities of haw pits and drying them; immersing haw pits in water and then dripping and charging the dried pit into the furnace for dry distillation; gradually raising the temperature and dry distilling the haw pits at two temperature ranges of 105-195° C. and 305-380° C. respectively and collecting the distillate; mixing together the distillate, allowing them to separate into layers by specific gravity difference and separating out the final brownish red transparent liquor by siphon. The method of the present invention can provide high yield of extraction and the present device is simple in structure. Further, the present invention is easy to be employed on the industrial scale.

Abstract: The present invention describes food supplements that contain one or more fruit extracts useful for pain relief and anti-inflammation. The food supplements may be used to inhibit inflammation mediated by cyclooxygenase and more particularly by cyclooxygenase-2.

Abstract: Implementation is directed to selectively inhibiting estrogen production and providing estrogenic effects in a human body. A dietary supplement includes a processed Morinda citrifolia product that is used to inhibit aromatase or aromatase enzymes that function to convert androgens to estrogens, inhibit receptors from binding with estrogen, and reduce and/or regulate estrogen production, as well as reduce the amount of estrogen produced within the body and regulating such production. The dietary supplement further provides estrogenic effects. The present invention methods and compositions effectively function to treat estrogen-dependent cancers, and particularly inhibit, destroy, and reverse the effects of of estrogen-dependent cancerous tumors through the introduction into the body (e.g. ingesting) a safe, pre-determined dosage of a naturaceutical composition formulated with or comprising one or more processed Morinda citrifolia products for a safe, pre-determined duration.

Abstract: Methods and formulations for using Tahitian Noni juice for inhibiting naturally occurring phosphodiesterases (PDEs). The present invention relates to Tahitian Noni juice as a PDE inhibitor to increase body energy and reduce allergy and asthma reactions.

Abstract: A process of making a supplement for digestive ailment includes the steps of (a) soaking a raw composition which consists of 39.22% by weight of Radix Angelicae Sinensis, 39.22% by weight of Radix Paeoniae Alba, 3.92% by weight of Semen Arecae, 5.88% by weight of Talcum, 1.96% by weight of Radix Saussureae Lappae, 1.96% by weight of Semen Raphani, 3.92% by weight of Fructus Aurantii, and 3.92% by weight of Radix Glycyrrhizae, in a predetermined volume of water for a predetermined soaking time to form a pre-decocting solution and a pre-decocting composition; (b) heating said pre-decocting solution and said pre-decocting composition for a predetermined period of decocting time to form a mixture consisting of a residual composition and a supplement in solution; wherein a volume ratio of said supplement in solution and said water in the step (a) is approximately 1:3; and (c) separating said residual composition and said supplement in solution.

Abstract: The present invention is directed to methods of inhibiting Aromatase or Aromatase enzymes that function to convert androgens to estrogens, inhibiting receptors from binding with estrogen, and reducing and/or regulating estrogen production, as well as reducing the amount of estrogen produced within the body and regulating such production. The present invention methods and compositions effectively function to treat estrogen-dependent cancers, and particularly inhibit, destroy, and reverse the effects of of estrogen-dependent cancerous tumors through the introduction into the body (e.g. ingesting) a safe, pre-determined dosage of a naturaceutical composition formulated with or comprising one or more processed Morinda citrifolia products for a safe, pre-determined duration.

Abstract: A pharmaceutical composition for the prophylaxis and treatment of osteoporosis is provided. The composition is extracted from a mixture including Semen cuscutae, or Fructus cindii and Semen cuscutae, and then purified to obtain a large amount of active ingredients, such as coumarins and flavanoids. The pharmaceutical composition made from Semen cuscutae only is also effective. The aforesaid pharmaceutical composition can also be used with calcium and/or vitamin D3.

Abstract: Methods and compositions are disclosed for prevention or treatment of prostate disorders and ameliorating symptoms thereof, including prostatitis, benign prostate hyperplasia and prostatic carcinoma.

Abstract: The invention provides a new formulation of the composition comprising Flos Lonicerae Fructus Forsythiae and Radix Scutellariae. This invention also provides a method for identification with HPLC and the characteristic peaks of the compositions of said composition. The composition possesses antiviral effective, namely, inhibition of influenza virus, parainfluenza virus, herpes I virus and herpes II virus. The invention refers to a method for preparation and control of the active components of Flos Lonicerae Fructus Forsythiae and Radix Scutellariae for its biological activity. The invention also provides a unique raw materials and intermediate formulation.

Abstract: This invention includes both a one-column process and a two-column process for the preparation of compositions enriched for anthocyanins from a crude plant extract. Both processes include a novel column purification step using a brominated polystyrene resin. This invention also includes extracts enriched for anthocyanins.

Abstract: The invention concerns cosmetic and/or pharmaceutical and/or dermatological compositions and methods for preparing them. The composition is characterized in that it comprises a mixture called base mixture, consisting of a liquid extracted from a mixture (M) of tomatoes and apples once the spontaneous chemical reaction initiated by the mixture of the two crushed plants is completed. The invention is applicable to skin care.

Abstract: There are provided topical cosmetic compositions for improving the aesthetic appearance of skin and remediating the effects of aging, and methods of use thereof. One composition is a blend of neem seed cell broth and one or more additional botanical ingredients. Another composition has pomegranate fruit extract and, optionally, one or more additional botanical ingredients.

Abstract: A vitamin C based dietary supplement product is revealed with enhanced flavor characteristics. Vitamin C sources are combined with extracts of the fruit of Lo Han and/or extracts from the leaves of Stevia and/or extracts from the leaves of Chinese Blackberry. The resulting product is a pleasant tasting dietary supplement, which is easily absorbed by the body in liquid form, and provides substantial therapeutic effects.

Abstract: The present invention provides a process to extract oil from Momordica cochinchinensis aril to yield an edible oil rich in &bgr;-carotene. The process can be carried out without the use of any harmful organic solvents, and provides products containing other carotenoids, such as lycopene, and fiber and vitamin E. This invention provides a bioavailable and stable source of &bgr;-carotene, a pro-vitamin A carotenoid, in areas where vitamin A deficiency exists. Products derived from this invention serve as a safe source of antioxidants and nutritional supplement for human and animal consumption, and for the pharmaceuticals and cosmetics industries as well as providing a suitable, effective food additives and colorants.

Abstract: Nutraceutical compositions derived from the fruit of the Garcinia mangostana L. or mangosteen plant are provided. The nutraceutical mangosteen compositions employ novel combinations of mangosteen fruit pulp and pericarp, and can be additionally complemented by selected juice concentrates to yield a composition for improving general health and wellness in humans.

Abstract: This invention provides a composition comprising extracts from the husk of Wenguanguo and a process of producing the combined extract comprising the following steps: extracting Wenguanguo husks with an organic solvent to form an organic extract; removing the organic solvent from the extract to form aqueous extracts; and drying and sterilizing the aqueous extracts to form the combined extracts. The extracts can be used to make medicines or health foods for preventing cerebral aging, improving memory, improving cerebral functions and curing enuresis, frequent micturition, urinary incontinence, dementia, weak intelligence and Alzheimer's disease, autism, brain trauma, Parkinson's disease and other diseases caused by cerebral dysfunction and treating arthritis, rheumatism, poor circulation, arteriosclerosis, Raynaud's syndrome. The combined extracts contain saponin, saccharides, proteins and others.

Abstract: An herbal-based treatment for Hepatitis C includes boiling a filtered residue from the Ecballium Elaterium plant to form a condensate. This condensate is mixed with water and administered in the form of drops. The drops were given to human patients, along with a single herb, Camelthorn, in a powder form. The combined herbal-based treatment was administered to human beings who were chronically infected with Hepatitis C. These patients, in terms of reduction of viral loads, normalization of enzymes, and general well being, were treated successfully in most instances.

Abstract: A broad spectrum anti-viral includes a condensate, made by boiling a filtered residue of the Ecbalium Elaterium plant. The condensate, mixed with water, has been successfully used to treat humans for Hepatitis C, Hepatitis B, Influenza, and the Common Cold. The condensate was also subject in vitro assays. These assays showed anti-viral activity, with an acceptable level of toxicity.

Abstract: Disclosed is a novel anti-inflammatory pharmaceutical composition that exhibits potent and selective inhibition of the cycloooxygenase-2 (COX-2) enzyme. The formulation consists of a hops extract that exhibits COX-2 selectivity as defined by dividing the IC50 COX-2/IC50COX-1 concentrations that are determined by testing with the William Harvey Whole Blood Assay (WHMA), and falls in the range of 0.011 to 0.2. Such compositions may also optionally contain high levels of alpha acids and low levels of beta acids, some flavonoid compounds, and virtually no essential oils. Such compositions are useful for treating conditions that manifest as inflammatory pain, or are impacted by the COX-2 enzyme. The recited compositions are particularly beneficial for treating osteoarthritis and rheumatoid arthritis, and can be used for chronic pain with reduced gastric side-effects.

Abstract: Dietary supplements include a complementary blend of fruits including at least noni and Luo Han Guo. Other fruits having a high ORAC value, such as blueberries and raspberries, are also preferably incorporated. The combination of the Luo Han Guo and noni masks the noni's flavors and odors while sweetening the dietary supplements. The Luo Han Guo can be simultaneously provided in both powder and liquid form so that the liquid form acts as the primary sweetener while the powder form acts as the primary masker. The dietary supplements also have an enhanced natural preservative effect, providing an extended shelf life without the use of artificial preservatives.

Abstract: A food supplement formulation effective to improve the function of the liver comprises selenium, milk thistle seed, phosphatidyl choline, dandelion root, l-methionine, l-taurine, N-acetyl-cysteine, alpha lipoic arid, artichoke leaf, green tea leaf, turmeric root, belleric myrobalan fruit, boerhavia diffusa, eclipta alba, wedelolactones tinospora cordifolia, andrographis paniculata, and picrorhiza kurroa.

Abstract: Compositions and methods are provided for aiding human beings to complete emptying of the bladder, to reduce urination frequency, to alleviate the urgency and difficulty in postponing urination, to lessen the interruption in urinating, to increase the urinary stream flow, to facilitate the beginning of urination, to reduce nocturia, or to increase libido. These advantages are achieved by administering to a human being a preparation with at least a part of at least one plant in family Asteraceae. Preparations from a part of the plant Wyethia amplexicaulis are preferred. Other examples of suitable plants include Balsamorhiza sagittata, Helianthella uniflora, and Tragopogon dubius. The treatment composition may include parts of the plants or an active agent obtained from one of these plants and isolated or a synthetic equivalent.

Abstract: The invention relates to a novel composition containing an extract obtained from the plant Murraya koenigii and useful for the treatment or providing relief from acute asthma, and a process for the preparation of a lyophilized extract containing active principles of the plant Murraya koenigii, and a method for the treatment of asthma.

Abstract: The present invention includes compositions and methods of treating and preventing prostate and urinary problems in human males. Additionally, methods of digestive system improvement, blood circulation system improvement, liver and kidney system improvement and urinary system improvement are included.

Abstract: This application relates to a material which is suitable for the treatment of atopic disease, non-atopic eczema or psoriasis. The material can be extracted from a freeze-dried decoction of a mixture comprising the following Chinese herbs: Radix Ledebouriella, Fructus Tribuli, Herba Potentilla chinensis, Caulis Clematis armandii, Radix Rehmannia, Radix Glycyrrhiza, Radix Paeonia rubra, Cortex Dictamni radicis, Herba Lopatheri, Spica Schizonepetae. The material comprises one or more of those components present in the freeze-dried decoction which run with Rf values in the ranges 0.00 to 0.100, 0.167 to 0.300, 0.400 to 0.533, 0.700 to 0.833 or 0.900 to 0.967 if the freeze-dried decoction is diluted in aqueous solution and subjected to chromatography on a Whatman 2 cms×55 cms×3 mm cellulose strip for 10 hours using a solvent mixture of butanol, ethanol and water in the proportions 4:1:1.

Abstract: A cosmetic and/or pharmaceutical composition containing an extract from a pericarp of a Litchi chinensis Sonn. plant, and wherein the composition is used to protect human skin and/or hair from environmental influences and ageing.

Abstract: The invention concerns the field of biochemistry, and more precisely biological substances of vegetable origin. The invention concerns substances having non-cytotoxic biological activity, extracted from plants with CAM metabolism, such as plants of the Cactacees, Crassulacees and Saxifragacees family. The invention also concerns the method for obtaining these substances as well as compositions containing them. Said compositions are designed for accelerating and amplifying the synthesis of thermal shock proteins of cells of living beings in vivo or in vitro.